Global Oncology/Cancer Drugs Market Growth 2022-2028
The report requires updating with new data and is sent in 48 hours after order is placed.
As the global economy mends, the 2021 growth of Oncology/Cancer Drugs will have significant change from previous year. According to our (LP Information) latest study, the global Oncology/Cancer Drugs market size is USD million in 2022 from USD 91580 million in 2021, with a change of % between 2021 and 2022. The global Oncology/Cancer Drugs market size will reach USD 124300 million in 2028, growing at a CAGR of 4.5% over the analysis period.
The United States Oncology/Cancer Drugs market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Oncology/Cancer Drugs market, reaching US$ million by the year 2028. As for the Europe Oncology/Cancer Drugs landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Oncology/Cancer Drugs players cover Roche, HENGRUI, AstraZeneca, and QILU, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Oncology/Cancer Drugs market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
As the global economy mends, the 2021 growth of Oncology/Cancer Drugs will have significant change from previous year. According to our (LP Information) latest study, the global Oncology/Cancer Drugs market size is USD million in 2022 from USD 91580 million in 2021, with a change of % between 2021 and 2022. The global Oncology/Cancer Drugs market size will reach USD 124300 million in 2028, growing at a CAGR of 4.5% over the analysis period.
The United States Oncology/Cancer Drugs market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Oncology/Cancer Drugs market, reaching US$ million by the year 2028. As for the Europe Oncology/Cancer Drugs landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Oncology/Cancer Drugs players cover Roche, HENGRUI, AstraZeneca, and QILU, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Oncology/Cancer Drugs market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
- Antimetabolite
- Alkaloid drugs
- Hormone
- Targeted drug
- Platinum-based drugs
- Other
- Blood Cancer
- Breast Cancer
- Gastrointestinal Cancer
- Prostate Cancer
- Respiratory/Lung Cancer
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Roche
- HENGRUI
- AstraZeneca
- QILU
- Sanofi
- HANSOH
- LUYE
- Novartis
- GuiZhou YiBai
- Lunan
- Eli Lilly and Company
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Oncology/Cancer Drugs Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Oncology/Cancer Drugs by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Oncology/Cancer Drugs by Country/Region, 2017, 2022 & 2028
2.2 Oncology/Cancer Drugs Segment by Type
2.2.1 Antimetabolite
2.2.2 Alkaloid drugs
2.2.3 Hormone
2.2.4 Targeted drug
2.2.5 Platinum-based drugs
2.2.6 Other
2.3 Oncology/Cancer Drugs Sales by Type
2.3.1 Global Oncology/Cancer Drugs Sales Market Share by Type (2017-2022)
2.3.2 Global Oncology/Cancer Drugs Revenue and Market Share by Type (2017-2022)
2.3.3 Global Oncology/Cancer Drugs Sale Price by Type (2017-2022)
2.4 Oncology/Cancer Drugs Segment by Application
2.4.1 Blood Cancer
2.4.2 Breast Cancer
2.4.3 Gastrointestinal Cancer
2.4.4 Prostate Cancer
2.4.5 Respiratory/Lung Cancer
2.4.6 Other
2.5 Oncology/Cancer Drugs Sales by Application
2.5.1 Global Oncology/Cancer Drugs Sale Market Share by Application (2017-2022)
2.5.2 Global Oncology/Cancer Drugs Revenue and Market Share by Application (2017-2022)
2.5.3 Global Oncology/Cancer Drugs Sale Price by Application (2017-2022)
3 GLOBAL ONCOLOGY/CANCER DRUGS BY COMPANY
3.1 Global Oncology/Cancer Drugs Breakdown Data by Company
3.1.1 Global Oncology/Cancer Drugs Annual Sales by Company (2020-2022)
3.1.2 Global Oncology/Cancer Drugs Sales Market Share by Company (2020-2022)
3.2 Global Oncology/Cancer Drugs Annual Revenue by Company (2020-2022)
3.2.1 Global Oncology/Cancer Drugs Revenue by Company (2020-2022)
3.2.2 Global Oncology/Cancer Drugs Revenue Market Share by Company (2020-2022)
3.3 Global Oncology/Cancer Drugs Sale Price by Company
3.4 Key Manufacturers Oncology/Cancer Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Oncology/Cancer Drugs Product Location Distribution
3.4.2 Players Oncology/Cancer Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR ONCOLOGY/CANCER DRUGS BY GEOGRAPHIC REGION
4.1 World Historic Oncology/Cancer Drugs Market Size by Geographic Region (2017-2022)
4.1.1 Global Oncology/Cancer Drugs Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Oncology/Cancer Drugs Annual Revenue by Geographic Region
4.2 World Historic Oncology/Cancer Drugs Market Size by Country/Region (2017-2022)
4.2.1 Global Oncology/Cancer Drugs Annual Sales by Country/Region (2017-2022)
4.2.2 Global Oncology/Cancer Drugs Annual Revenue by Country/Region
4.3 Americas Oncology/Cancer Drugs Sales Growth
4.4 APAC Oncology/Cancer Drugs Sales Growth
4.5 Europe Oncology/Cancer Drugs Sales Growth
4.6 Middle East & Africa Oncology/Cancer Drugs Sales Growth
5 AMERICAS
5.1 Americas Oncology/Cancer Drugs Sales by Country
5.1.1 Americas Oncology/Cancer Drugs Sales by Country (2017-2022)
5.1.2 Americas Oncology/Cancer Drugs Revenue by Country (2017-2022)
5.2 Americas Oncology/Cancer Drugs Sales by Type
5.3 Americas Oncology/Cancer Drugs Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Oncology/Cancer Drugs Sales by Region
6.1.1 APAC Oncology/Cancer Drugs Sales by Region (2017-2022)
6.1.2 APAC Oncology/Cancer Drugs Revenue by Region (2017-2022)
6.2 APAC Oncology/Cancer Drugs Sales by Type
6.3 APAC Oncology/Cancer Drugs Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Oncology/Cancer Drugs by Country
7.1.1 Europe Oncology/Cancer Drugs Sales by Country (2017-2022)
7.1.2 Europe Oncology/Cancer Drugs Revenue by Country (2017-2022)
7.2 Europe Oncology/Cancer Drugs Sales by Type
7.3 Europe Oncology/Cancer Drugs Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Oncology/Cancer Drugs by Country
8.1.1 Middle East & Africa Oncology/Cancer Drugs Sales by Country (2017-2022)
8.1.2 Middle East & Africa Oncology/Cancer Drugs Revenue by Country (2017-2022)
8.2 Middle East & Africa Oncology/Cancer Drugs Sales by Type
8.3 Middle East & Africa Oncology/Cancer Drugs Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Oncology/Cancer Drugs
10.3 Manufacturing Process Analysis of Oncology/Cancer Drugs
10.4 Industry Chain Structure of Oncology/Cancer Drugs
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Oncology/Cancer Drugs Distributors
11.3 Oncology/Cancer Drugs Customer
12 WORLD FORECAST REVIEW FOR ONCOLOGY/CANCER DRUGS BY GEOGRAPHIC REGION
12.1 Global Oncology/Cancer Drugs Market Size Forecast by Region
12.1.1 Global Oncology/Cancer Drugs Forecast by Region (2023-2028)
12.1.2 Global Oncology/Cancer Drugs Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Oncology/Cancer Drugs Forecast by Type
12.7 Global Oncology/Cancer Drugs Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Roche
13.1.1 Roche Company Information
13.1.2 Roche Oncology/Cancer Drugs Product Offered
13.1.3 Roche Oncology/Cancer Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Roche Main Business Overview
13.1.5 Roche Latest Developments
13.2 HENGRUI
13.2.1 HENGRUI Company Information
13.2.2 HENGRUI Oncology/Cancer Drugs Product Offered
13.2.3 HENGRUI Oncology/Cancer Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 HENGRUI Main Business Overview
13.2.5 HENGRUI Latest Developments
13.3 AstraZeneca
13.3.1 AstraZeneca Company Information
13.3.2 AstraZeneca Oncology/Cancer Drugs Product Offered
13.3.3 AstraZeneca Oncology/Cancer Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 AstraZeneca Main Business Overview
13.3.5 AstraZeneca Latest Developments
13.4 QILU
13.4.1 QILU Company Information
13.4.2 QILU Oncology/Cancer Drugs Product Offered
13.4.3 QILU Oncology/Cancer Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 QILU Main Business Overview
13.4.5 QILU Latest Developments
13.5 Sanofi
13.5.1 Sanofi Company Information
13.5.2 Sanofi Oncology/Cancer Drugs Product Offered
13.5.3 Sanofi Oncology/Cancer Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Sanofi Main Business Overview
13.5.5 Sanofi Latest Developments
13.6 HANSOH
13.6.1 HANSOH Company Information
13.6.2 HANSOH Oncology/Cancer Drugs Product Offered
13.6.3 HANSOH Oncology/Cancer Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 HANSOH Main Business Overview
13.6.5 HANSOH Latest Developments
13.7 LUYE
13.7.1 LUYE Company Information
13.7.2 LUYE Oncology/Cancer Drugs Product Offered
13.7.3 LUYE Oncology/Cancer Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 LUYE Main Business Overview
13.7.5 LUYE Latest Developments
13.8 Novartis
13.8.1 Novartis Company Information
13.8.2 Novartis Oncology/Cancer Drugs Product Offered
13.8.3 Novartis Oncology/Cancer Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Novartis Main Business Overview
13.8.5 Novartis Latest Developments
13.9 GuiZhou YiBai
13.9.1 GuiZhou YiBai Company Information
13.9.2 GuiZhou YiBai Oncology/Cancer Drugs Product Offered
13.9.3 GuiZhou YiBai Oncology/Cancer Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 GuiZhou YiBai Main Business Overview
13.9.5 GuiZhou YiBai Latest Developments
13.10 Lunan
13.10.1 Lunan Company Information
13.10.2 Lunan Oncology/Cancer Drugs Product Offered
13.10.3 Lunan Oncology/Cancer Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Lunan Main Business Overview
13.10.5 Lunan Latest Developments
13.11 Eli Lilly and Company
13.11.1 Eli Lilly and Company Company Information
13.11.2 Eli Lilly and Company Oncology/Cancer Drugs Product Offered
13.11.3 Eli Lilly and Company Oncology/Cancer Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Eli Lilly and Company Main Business Overview
13.11.5 Eli Lilly and Company Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Oncology/Cancer Drugs Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Oncology/Cancer Drugs by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Oncology/Cancer Drugs by Country/Region, 2017, 2022 & 2028
2.2 Oncology/Cancer Drugs Segment by Type
2.2.1 Antimetabolite
2.2.2 Alkaloid drugs
2.2.3 Hormone
2.2.4 Targeted drug
2.2.5 Platinum-based drugs
2.2.6 Other
2.3 Oncology/Cancer Drugs Sales by Type
2.3.1 Global Oncology/Cancer Drugs Sales Market Share by Type (2017-2022)
2.3.2 Global Oncology/Cancer Drugs Revenue and Market Share by Type (2017-2022)
2.3.3 Global Oncology/Cancer Drugs Sale Price by Type (2017-2022)
2.4 Oncology/Cancer Drugs Segment by Application
2.4.1 Blood Cancer
2.4.2 Breast Cancer
2.4.3 Gastrointestinal Cancer
2.4.4 Prostate Cancer
2.4.5 Respiratory/Lung Cancer
2.4.6 Other
2.5 Oncology/Cancer Drugs Sales by Application
2.5.1 Global Oncology/Cancer Drugs Sale Market Share by Application (2017-2022)
2.5.2 Global Oncology/Cancer Drugs Revenue and Market Share by Application (2017-2022)
2.5.3 Global Oncology/Cancer Drugs Sale Price by Application (2017-2022)
3 GLOBAL ONCOLOGY/CANCER DRUGS BY COMPANY
3.1 Global Oncology/Cancer Drugs Breakdown Data by Company
3.1.1 Global Oncology/Cancer Drugs Annual Sales by Company (2020-2022)
3.1.2 Global Oncology/Cancer Drugs Sales Market Share by Company (2020-2022)
3.2 Global Oncology/Cancer Drugs Annual Revenue by Company (2020-2022)
3.2.1 Global Oncology/Cancer Drugs Revenue by Company (2020-2022)
3.2.2 Global Oncology/Cancer Drugs Revenue Market Share by Company (2020-2022)
3.3 Global Oncology/Cancer Drugs Sale Price by Company
3.4 Key Manufacturers Oncology/Cancer Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Oncology/Cancer Drugs Product Location Distribution
3.4.2 Players Oncology/Cancer Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR ONCOLOGY/CANCER DRUGS BY GEOGRAPHIC REGION
4.1 World Historic Oncology/Cancer Drugs Market Size by Geographic Region (2017-2022)
4.1.1 Global Oncology/Cancer Drugs Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Oncology/Cancer Drugs Annual Revenue by Geographic Region
4.2 World Historic Oncology/Cancer Drugs Market Size by Country/Region (2017-2022)
4.2.1 Global Oncology/Cancer Drugs Annual Sales by Country/Region (2017-2022)
4.2.2 Global Oncology/Cancer Drugs Annual Revenue by Country/Region
4.3 Americas Oncology/Cancer Drugs Sales Growth
4.4 APAC Oncology/Cancer Drugs Sales Growth
4.5 Europe Oncology/Cancer Drugs Sales Growth
4.6 Middle East & Africa Oncology/Cancer Drugs Sales Growth
5 AMERICAS
5.1 Americas Oncology/Cancer Drugs Sales by Country
5.1.1 Americas Oncology/Cancer Drugs Sales by Country (2017-2022)
5.1.2 Americas Oncology/Cancer Drugs Revenue by Country (2017-2022)
5.2 Americas Oncology/Cancer Drugs Sales by Type
5.3 Americas Oncology/Cancer Drugs Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Oncology/Cancer Drugs Sales by Region
6.1.1 APAC Oncology/Cancer Drugs Sales by Region (2017-2022)
6.1.2 APAC Oncology/Cancer Drugs Revenue by Region (2017-2022)
6.2 APAC Oncology/Cancer Drugs Sales by Type
6.3 APAC Oncology/Cancer Drugs Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Oncology/Cancer Drugs by Country
7.1.1 Europe Oncology/Cancer Drugs Sales by Country (2017-2022)
7.1.2 Europe Oncology/Cancer Drugs Revenue by Country (2017-2022)
7.2 Europe Oncology/Cancer Drugs Sales by Type
7.3 Europe Oncology/Cancer Drugs Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Oncology/Cancer Drugs by Country
8.1.1 Middle East & Africa Oncology/Cancer Drugs Sales by Country (2017-2022)
8.1.2 Middle East & Africa Oncology/Cancer Drugs Revenue by Country (2017-2022)
8.2 Middle East & Africa Oncology/Cancer Drugs Sales by Type
8.3 Middle East & Africa Oncology/Cancer Drugs Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Oncology/Cancer Drugs
10.3 Manufacturing Process Analysis of Oncology/Cancer Drugs
10.4 Industry Chain Structure of Oncology/Cancer Drugs
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Oncology/Cancer Drugs Distributors
11.3 Oncology/Cancer Drugs Customer
12 WORLD FORECAST REVIEW FOR ONCOLOGY/CANCER DRUGS BY GEOGRAPHIC REGION
12.1 Global Oncology/Cancer Drugs Market Size Forecast by Region
12.1.1 Global Oncology/Cancer Drugs Forecast by Region (2023-2028)
12.1.2 Global Oncology/Cancer Drugs Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Oncology/Cancer Drugs Forecast by Type
12.7 Global Oncology/Cancer Drugs Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Roche
13.1.1 Roche Company Information
13.1.2 Roche Oncology/Cancer Drugs Product Offered
13.1.3 Roche Oncology/Cancer Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Roche Main Business Overview
13.1.5 Roche Latest Developments
13.2 HENGRUI
13.2.1 HENGRUI Company Information
13.2.2 HENGRUI Oncology/Cancer Drugs Product Offered
13.2.3 HENGRUI Oncology/Cancer Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 HENGRUI Main Business Overview
13.2.5 HENGRUI Latest Developments
13.3 AstraZeneca
13.3.1 AstraZeneca Company Information
13.3.2 AstraZeneca Oncology/Cancer Drugs Product Offered
13.3.3 AstraZeneca Oncology/Cancer Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 AstraZeneca Main Business Overview
13.3.5 AstraZeneca Latest Developments
13.4 QILU
13.4.1 QILU Company Information
13.4.2 QILU Oncology/Cancer Drugs Product Offered
13.4.3 QILU Oncology/Cancer Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 QILU Main Business Overview
13.4.5 QILU Latest Developments
13.5 Sanofi
13.5.1 Sanofi Company Information
13.5.2 Sanofi Oncology/Cancer Drugs Product Offered
13.5.3 Sanofi Oncology/Cancer Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Sanofi Main Business Overview
13.5.5 Sanofi Latest Developments
13.6 HANSOH
13.6.1 HANSOH Company Information
13.6.2 HANSOH Oncology/Cancer Drugs Product Offered
13.6.3 HANSOH Oncology/Cancer Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 HANSOH Main Business Overview
13.6.5 HANSOH Latest Developments
13.7 LUYE
13.7.1 LUYE Company Information
13.7.2 LUYE Oncology/Cancer Drugs Product Offered
13.7.3 LUYE Oncology/Cancer Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 LUYE Main Business Overview
13.7.5 LUYE Latest Developments
13.8 Novartis
13.8.1 Novartis Company Information
13.8.2 Novartis Oncology/Cancer Drugs Product Offered
13.8.3 Novartis Oncology/Cancer Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Novartis Main Business Overview
13.8.5 Novartis Latest Developments
13.9 GuiZhou YiBai
13.9.1 GuiZhou YiBai Company Information
13.9.2 GuiZhou YiBai Oncology/Cancer Drugs Product Offered
13.9.3 GuiZhou YiBai Oncology/Cancer Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 GuiZhou YiBai Main Business Overview
13.9.5 GuiZhou YiBai Latest Developments
13.10 Lunan
13.10.1 Lunan Company Information
13.10.2 Lunan Oncology/Cancer Drugs Product Offered
13.10.3 Lunan Oncology/Cancer Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Lunan Main Business Overview
13.10.5 Lunan Latest Developments
13.11 Eli Lilly and Company
13.11.1 Eli Lilly and Company Company Information
13.11.2 Eli Lilly and Company Oncology/Cancer Drugs Product Offered
13.11.3 Eli Lilly and Company Oncology/Cancer Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Eli Lilly and Company Main Business Overview
13.11.5 Eli Lilly and Company Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Oncology/Cancer Drugs Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Oncology/Cancer Drugs Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Antimetabolite
Table 4. Major Players of Alkaloid drugs
Table 5. Major Players of Hormone
Table 6. Major Players of Targeted drug
Table 7. Major Players of Platinum-based drugs
Table 8. Major Players of Other
Table 9. Global Oncology/Cancer Drugs Sales by Type (2017-2022) & (K MT)
Table 10. Global Oncology/Cancer Drugs Sales Market Share by Type (2017-2022)
Table 11. Global Oncology/Cancer Drugs Revenue by Type (2017-2022) & ($ million)
Table 12. Global Oncology/Cancer Drugs Revenue Market Share by Type (2017-2022)
Table 13. Global Oncology/Cancer Drugs Sale Price by Type (2017-2022) & (USD/MT)
Table 14. Global Oncology/Cancer Drugs Sales by Application (2017-2022) & (K MT)
Table 15. Global Oncology/Cancer Drugs Sales Market Share by Application (2017-2022)
Table 16. Global Oncology/Cancer Drugs Revenue by Application (2017-2022)
Table 17. Global Oncology/Cancer Drugs Revenue Market Share by Application (2017-2022)
Table 18. Global Oncology/Cancer Drugs Sale Price by Application (2017-2022) & (USD/MT)
Table 19. Global Oncology/Cancer Drugs Sales by Company (2020-2022) & (K MT)
Table 20. Global Oncology/Cancer Drugs Sales Market Share by Company (2020-2022)
Table 21. Global Oncology/Cancer Drugs Revenue by Company (2020-2022) ($ Millions)
Table 22. Global Oncology/Cancer Drugs Revenue Market Share by Company (2020-2022)
Table 23. Global Oncology/Cancer Drugs Sale Price by Company (2020-2022) & (USD/MT)
Table 24. Key Manufacturers Oncology/Cancer Drugs Producing Area Distribution and Sales Area
Table 25. Players Oncology/Cancer Drugs Products Offered
Table 26. Oncology/Cancer Drugs Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 27. New Products and Potential Entrants
Table 28. Mergers & Acquisitions, Expansion
Table 29. Global Oncology/Cancer Drugs Sales by Geographic Region (2017-2022) & (K MT)
Table 30. Global Oncology/Cancer Drugs Sales Market Share Geographic Region (2017-2022)
Table 31. Global Oncology/Cancer Drugs Revenue by Geographic Region (2017-2022) & ($ millions)
Table 32. Global Oncology/Cancer Drugs Revenue Market Share by Geographic Region (2017-2022)
Table 33. Global Oncology/Cancer Drugs Sales by Country/Region (2017-2022) & (K MT)
Table 34. Global Oncology/Cancer Drugs Sales Market Share by Country/Region (2017-2022)
Table 35. Global Oncology/Cancer Drugs Revenue by Country/Region (2017-2022) & ($ millions)
Table 36. Global Oncology/Cancer Drugs Revenue Market Share by Country/Region (2017-2022)
Table 37. Americas Oncology/Cancer Drugs Sales by Country (2017-2022) & (K MT)
Table 38. Americas Oncology/Cancer Drugs Sales Market Share by Country (2017-2022)
Table 39. Americas Oncology/Cancer Drugs Revenue by Country (2017-2022) & ($ Millions)
Table 40. Americas Oncology/Cancer Drugs Revenue Market Share by Country (2017-2022)
Table 41. Americas Oncology/Cancer Drugs Sales by Type (2017-2022) & (K MT)
Table 42. Americas Oncology/Cancer Drugs Sales Market Share by Type (2017-2022)
Table 43. Americas Oncology/Cancer Drugs Sales by Application (2017-2022) & (K MT)
Table 44. Americas Oncology/Cancer Drugs Sales Market Share by Application (2017-2022)
Table 45. APAC Oncology/Cancer Drugs Sales by Region (2017-2022) & (K MT)
Table 46. APAC Oncology/Cancer Drugs Sales Market Share by Region (2017-2022)
Table 47. APAC Oncology/Cancer Drugs Revenue by Region (2017-2022) & ($ Millions)
Table 48. APAC Oncology/Cancer Drugs Revenue Market Share by Region (2017-2022)
Table 49. APAC Oncology/Cancer Drugs Sales by Type (2017-2022) & (K MT)
Table 50. APAC Oncology/Cancer Drugs Sales Market Share by Type (2017-2022)
Table 51. APAC Oncology/Cancer Drugs Sales by Application (2017-2022) & (K MT)
Table 52. APAC Oncology/Cancer Drugs Sales Market Share by Application (2017-2022)
Table 53. Europe Oncology/Cancer Drugs Sales by Country (2017-2022) & (K MT)
Table 54. Europe Oncology/Cancer Drugs Sales Market Share by Country (2017-2022)
Table 55. Europe Oncology/Cancer Drugs Revenue by Country (2017-2022) & ($ Millions)
Table 56. Europe Oncology/Cancer Drugs Revenue Market Share by Country (2017-2022)
Table 57. Europe Oncology/Cancer Drugs Sales by Type (2017-2022) & (K MT)
Table 58. Europe Oncology/Cancer Drugs Sales Market Share by Type (2017-2022)
Table 59. Europe Oncology/Cancer Drugs Sales by Application (2017-2022) & (K MT)
Table 60. Europe Oncology/Cancer Drugs Sales Market Share by Application (2017-2022)
Table 61. Middle East & Africa Oncology/Cancer Drugs Sales by Country (2017-2022) & (K MT)
Table 62. Middle East & Africa Oncology/Cancer Drugs Sales Market Share by Country (2017-2022)
Table 63. Middle East & Africa Oncology/Cancer Drugs Revenue by Country (2017-2022) & ($ Millions)
Table 64. Middle East & Africa Oncology/Cancer Drugs Revenue Market Share by Country (2017-2022)
Table 65. Middle East & Africa Oncology/Cancer Drugs Sales by Type (2017-2022) & (K MT)
Table 66. Middle East & Africa Oncology/Cancer Drugs Sales Market Share by Type (2017-2022)
Table 67. Middle East & Africa Oncology/Cancer Drugs Sales by Application (2017-2022) & (K MT)
Table 68. Middle East & Africa Oncology/Cancer Drugs Sales Market Share by Application (2017-2022)
Table 69. Key Market Drivers & Growth Opportunities of Oncology/Cancer Drugs
Table 70. Key Market Challenges & Risks of Oncology/Cancer Drugs
Table 71. Key Industry Trends of Oncology/Cancer Drugs
Table 72. Oncology/Cancer Drugs Raw Material
Table 73. Key Suppliers of Raw Materials
Table 74. Oncology/Cancer Drugs Distributors List
Table 75. Oncology/Cancer Drugs Customer List
Table 76. Global Oncology/Cancer Drugs Sales Forecast by Region (2023-2028) & (K MT)
Table 77. Global Oncology/Cancer Drugs Sales Market Forecast by Region
Table 78. Global Oncology/Cancer Drugs Revenue Forecast by Region (2023-2028) & ($ millions)
Table 79. Global Oncology/Cancer Drugs Revenue Market Share Forecast by Region (2023-2028)
Table 80. Americas Oncology/Cancer Drugs Sales Forecast by Country (2023-2028) & (K MT)
Table 81. Americas Oncology/Cancer Drugs Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. APAC Oncology/Cancer Drugs Sales Forecast by Region (2023-2028) & (K MT)
Table 83. APAC Oncology/Cancer Drugs Revenue Forecast by Region (2023-2028) & ($ millions)
Table 84. Europe Oncology/Cancer Drugs Sales Forecast by Country (2023-2028) & (K MT)
Table 85. Europe Oncology/Cancer Drugs Revenue Forecast by Country (2023-2028) & ($ millions)
Table 86. Middle East & Africa Oncology/Cancer Drugs Sales Forecast by Country (2023-2028) & (K MT)
Table 87. Middle East & Africa Oncology/Cancer Drugs Revenue Forecast by Country (2023-2028) & ($ millions)
Table 88. Global Oncology/Cancer Drugs Sales Forecast by Type (2023-2028) & (K MT)
Table 89. Global Oncology/Cancer Drugs Sales Market Share Forecast by Type (2023-2028)
Table 90. Global Oncology/Cancer Drugs Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 91. Global Oncology/Cancer Drugs Revenue Market Share Forecast by Type (2023-2028)
Table 92. Global Oncology/Cancer Drugs Sales Forecast by Application (2023-2028) & (K MT)
Table 93. Global Oncology/Cancer Drugs Sales Market Share Forecast by Application (2023-2028)
Table 94. Global Oncology/Cancer Drugs Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 95. Global Oncology/Cancer Drugs Revenue Market Share Forecast by Application (2023-2028)
Table 96. Roche Basic Information, Oncology/Cancer Drugs Manufacturing Base, Sales Area and Its Competitors
Table 97. Roche Oncology/Cancer Drugs Product Offered
Table 98. Roche Oncology/Cancer Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 99. Roche Main Business
Table 100. Roche Latest Developments
Table 101. HENGRUI Basic Information, Oncology/Cancer Drugs Manufacturing Base, Sales Area and Its Competitors
Table 102. HENGRUI Oncology/Cancer Drugs Product Offered
Table 103. HENGRUI Oncology/Cancer Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 104. HENGRUI Main Business
Table 105. HENGRUI Latest Developments
Table 106. AstraZeneca Basic Information, Oncology/Cancer Drugs Manufacturing Base, Sales Area and Its Competitors
Table 107. AstraZeneca Oncology/Cancer Drugs Product Offered
Table 108. AstraZeneca Oncology/Cancer Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 109. AstraZeneca Main Business
Table 110. AstraZeneca Latest Developments
Table 111. QILU Basic Information, Oncology/Cancer Drugs Manufacturing Base, Sales Area and Its Competitors
Table 112. QILU Oncology/Cancer Drugs Product Offered
Table 113. QILU Oncology/Cancer Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 114. QILU Main Business
Table 115. QILU Latest Developments
Table 116. Sanofi Basic Information, Oncology/Cancer Drugs Manufacturing Base, Sales Area and Its Competitors
Table 117. Sanofi Oncology/Cancer Drugs Product Offered
Table 118. Sanofi Oncology/Cancer Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 119. Sanofi Main Business
Table 120. Sanofi Latest Developments
Table 121. HANSOH Basic Information, Oncology/Cancer Drugs Manufacturing Base, Sales Area and Its Competitors
Table 122. HANSOH Oncology/Cancer Drugs Product Offered
Table 123. HANSOH Oncology/Cancer Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 124. HANSOH Main Business
Table 125. HANSOH Latest Developments
Table 126. LUYE Basic Information, Oncology/Cancer Drugs Manufacturing Base, Sales Area and Its Competitors
Table 127. LUYE Oncology/Cancer Drugs Product Offered
Table 128. LUYE Oncology/Cancer Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 129. LUYE Main Business
Table 130. LUYE Latest Developments
Table 131. Novartis Basic Information, Oncology/Cancer Drugs Manufacturing Base, Sales Area and Its Competitors
Table 132. Novartis Oncology/Cancer Drugs Product Offered
Table 133. Novartis Oncology/Cancer Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 134. Novartis Main Business
Table 135. Novartis Latest Developments
Table 136. GuiZhou YiBai Basic Information, Oncology/Cancer Drugs Manufacturing Base, Sales Area and Its Competitors
Table 137. GuiZhou YiBai Oncology/Cancer Drugs Product Offered
Table 138. GuiZhou YiBai Oncology/Cancer Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 139. GuiZhou YiBai Main Business
Table 140. GuiZhou YiBai Latest Developments
Table 141. Lunan Basic Information, Oncology/Cancer Drugs Manufacturing Base, Sales Area and Its Competitors
Table 142. Lunan Oncology/Cancer Drugs Product Offered
Table 143. Lunan Oncology/Cancer Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 144. Lunan Main Business
Table 145. Lunan Latest Developments
Table 146. Eli Lilly and Company Basic Information, Oncology/Cancer Drugs Manufacturing Base, Sales Area and Its Competitors
Table 147. Eli Lilly and Company Oncology/Cancer Drugs Product Offered
Table 148. Eli Lilly and Company Oncology/Cancer Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 149. Eli Lilly and Company Main Business
Table 150. Eli Lilly and Company Latest Developments
Table 1. Oncology/Cancer Drugs Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Oncology/Cancer Drugs Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Antimetabolite
Table 4. Major Players of Alkaloid drugs
Table 5. Major Players of Hormone
Table 6. Major Players of Targeted drug
Table 7. Major Players of Platinum-based drugs
Table 8. Major Players of Other
Table 9. Global Oncology/Cancer Drugs Sales by Type (2017-2022) & (K MT)
Table 10. Global Oncology/Cancer Drugs Sales Market Share by Type (2017-2022)
Table 11. Global Oncology/Cancer Drugs Revenue by Type (2017-2022) & ($ million)
Table 12. Global Oncology/Cancer Drugs Revenue Market Share by Type (2017-2022)
Table 13. Global Oncology/Cancer Drugs Sale Price by Type (2017-2022) & (USD/MT)
Table 14. Global Oncology/Cancer Drugs Sales by Application (2017-2022) & (K MT)
Table 15. Global Oncology/Cancer Drugs Sales Market Share by Application (2017-2022)
Table 16. Global Oncology/Cancer Drugs Revenue by Application (2017-2022)
Table 17. Global Oncology/Cancer Drugs Revenue Market Share by Application (2017-2022)
Table 18. Global Oncology/Cancer Drugs Sale Price by Application (2017-2022) & (USD/MT)
Table 19. Global Oncology/Cancer Drugs Sales by Company (2020-2022) & (K MT)
Table 20. Global Oncology/Cancer Drugs Sales Market Share by Company (2020-2022)
Table 21. Global Oncology/Cancer Drugs Revenue by Company (2020-2022) ($ Millions)
Table 22. Global Oncology/Cancer Drugs Revenue Market Share by Company (2020-2022)
Table 23. Global Oncology/Cancer Drugs Sale Price by Company (2020-2022) & (USD/MT)
Table 24. Key Manufacturers Oncology/Cancer Drugs Producing Area Distribution and Sales Area
Table 25. Players Oncology/Cancer Drugs Products Offered
Table 26. Oncology/Cancer Drugs Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 27. New Products and Potential Entrants
Table 28. Mergers & Acquisitions, Expansion
Table 29. Global Oncology/Cancer Drugs Sales by Geographic Region (2017-2022) & (K MT)
Table 30. Global Oncology/Cancer Drugs Sales Market Share Geographic Region (2017-2022)
Table 31. Global Oncology/Cancer Drugs Revenue by Geographic Region (2017-2022) & ($ millions)
Table 32. Global Oncology/Cancer Drugs Revenue Market Share by Geographic Region (2017-2022)
Table 33. Global Oncology/Cancer Drugs Sales by Country/Region (2017-2022) & (K MT)
Table 34. Global Oncology/Cancer Drugs Sales Market Share by Country/Region (2017-2022)
Table 35. Global Oncology/Cancer Drugs Revenue by Country/Region (2017-2022) & ($ millions)
Table 36. Global Oncology/Cancer Drugs Revenue Market Share by Country/Region (2017-2022)
Table 37. Americas Oncology/Cancer Drugs Sales by Country (2017-2022) & (K MT)
Table 38. Americas Oncology/Cancer Drugs Sales Market Share by Country (2017-2022)
Table 39. Americas Oncology/Cancer Drugs Revenue by Country (2017-2022) & ($ Millions)
Table 40. Americas Oncology/Cancer Drugs Revenue Market Share by Country (2017-2022)
Table 41. Americas Oncology/Cancer Drugs Sales by Type (2017-2022) & (K MT)
Table 42. Americas Oncology/Cancer Drugs Sales Market Share by Type (2017-2022)
Table 43. Americas Oncology/Cancer Drugs Sales by Application (2017-2022) & (K MT)
Table 44. Americas Oncology/Cancer Drugs Sales Market Share by Application (2017-2022)
Table 45. APAC Oncology/Cancer Drugs Sales by Region (2017-2022) & (K MT)
Table 46. APAC Oncology/Cancer Drugs Sales Market Share by Region (2017-2022)
Table 47. APAC Oncology/Cancer Drugs Revenue by Region (2017-2022) & ($ Millions)
Table 48. APAC Oncology/Cancer Drugs Revenue Market Share by Region (2017-2022)
Table 49. APAC Oncology/Cancer Drugs Sales by Type (2017-2022) & (K MT)
Table 50. APAC Oncology/Cancer Drugs Sales Market Share by Type (2017-2022)
Table 51. APAC Oncology/Cancer Drugs Sales by Application (2017-2022) & (K MT)
Table 52. APAC Oncology/Cancer Drugs Sales Market Share by Application (2017-2022)
Table 53. Europe Oncology/Cancer Drugs Sales by Country (2017-2022) & (K MT)
Table 54. Europe Oncology/Cancer Drugs Sales Market Share by Country (2017-2022)
Table 55. Europe Oncology/Cancer Drugs Revenue by Country (2017-2022) & ($ Millions)
Table 56. Europe Oncology/Cancer Drugs Revenue Market Share by Country (2017-2022)
Table 57. Europe Oncology/Cancer Drugs Sales by Type (2017-2022) & (K MT)
Table 58. Europe Oncology/Cancer Drugs Sales Market Share by Type (2017-2022)
Table 59. Europe Oncology/Cancer Drugs Sales by Application (2017-2022) & (K MT)
Table 60. Europe Oncology/Cancer Drugs Sales Market Share by Application (2017-2022)
Table 61. Middle East & Africa Oncology/Cancer Drugs Sales by Country (2017-2022) & (K MT)
Table 62. Middle East & Africa Oncology/Cancer Drugs Sales Market Share by Country (2017-2022)
Table 63. Middle East & Africa Oncology/Cancer Drugs Revenue by Country (2017-2022) & ($ Millions)
Table 64. Middle East & Africa Oncology/Cancer Drugs Revenue Market Share by Country (2017-2022)
Table 65. Middle East & Africa Oncology/Cancer Drugs Sales by Type (2017-2022) & (K MT)
Table 66. Middle East & Africa Oncology/Cancer Drugs Sales Market Share by Type (2017-2022)
Table 67. Middle East & Africa Oncology/Cancer Drugs Sales by Application (2017-2022) & (K MT)
Table 68. Middle East & Africa Oncology/Cancer Drugs Sales Market Share by Application (2017-2022)
Table 69. Key Market Drivers & Growth Opportunities of Oncology/Cancer Drugs
Table 70. Key Market Challenges & Risks of Oncology/Cancer Drugs
Table 71. Key Industry Trends of Oncology/Cancer Drugs
Table 72. Oncology/Cancer Drugs Raw Material
Table 73. Key Suppliers of Raw Materials
Table 74. Oncology/Cancer Drugs Distributors List
Table 75. Oncology/Cancer Drugs Customer List
Table 76. Global Oncology/Cancer Drugs Sales Forecast by Region (2023-2028) & (K MT)
Table 77. Global Oncology/Cancer Drugs Sales Market Forecast by Region
Table 78. Global Oncology/Cancer Drugs Revenue Forecast by Region (2023-2028) & ($ millions)
Table 79. Global Oncology/Cancer Drugs Revenue Market Share Forecast by Region (2023-2028)
Table 80. Americas Oncology/Cancer Drugs Sales Forecast by Country (2023-2028) & (K MT)
Table 81. Americas Oncology/Cancer Drugs Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. APAC Oncology/Cancer Drugs Sales Forecast by Region (2023-2028) & (K MT)
Table 83. APAC Oncology/Cancer Drugs Revenue Forecast by Region (2023-2028) & ($ millions)
Table 84. Europe Oncology/Cancer Drugs Sales Forecast by Country (2023-2028) & (K MT)
Table 85. Europe Oncology/Cancer Drugs Revenue Forecast by Country (2023-2028) & ($ millions)
Table 86. Middle East & Africa Oncology/Cancer Drugs Sales Forecast by Country (2023-2028) & (K MT)
Table 87. Middle East & Africa Oncology/Cancer Drugs Revenue Forecast by Country (2023-2028) & ($ millions)
Table 88. Global Oncology/Cancer Drugs Sales Forecast by Type (2023-2028) & (K MT)
Table 89. Global Oncology/Cancer Drugs Sales Market Share Forecast by Type (2023-2028)
Table 90. Global Oncology/Cancer Drugs Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 91. Global Oncology/Cancer Drugs Revenue Market Share Forecast by Type (2023-2028)
Table 92. Global Oncology/Cancer Drugs Sales Forecast by Application (2023-2028) & (K MT)
Table 93. Global Oncology/Cancer Drugs Sales Market Share Forecast by Application (2023-2028)
Table 94. Global Oncology/Cancer Drugs Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 95. Global Oncology/Cancer Drugs Revenue Market Share Forecast by Application (2023-2028)
Table 96. Roche Basic Information, Oncology/Cancer Drugs Manufacturing Base, Sales Area and Its Competitors
Table 97. Roche Oncology/Cancer Drugs Product Offered
Table 98. Roche Oncology/Cancer Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 99. Roche Main Business
Table 100. Roche Latest Developments
Table 101. HENGRUI Basic Information, Oncology/Cancer Drugs Manufacturing Base, Sales Area and Its Competitors
Table 102. HENGRUI Oncology/Cancer Drugs Product Offered
Table 103. HENGRUI Oncology/Cancer Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 104. HENGRUI Main Business
Table 105. HENGRUI Latest Developments
Table 106. AstraZeneca Basic Information, Oncology/Cancer Drugs Manufacturing Base, Sales Area and Its Competitors
Table 107. AstraZeneca Oncology/Cancer Drugs Product Offered
Table 108. AstraZeneca Oncology/Cancer Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 109. AstraZeneca Main Business
Table 110. AstraZeneca Latest Developments
Table 111. QILU Basic Information, Oncology/Cancer Drugs Manufacturing Base, Sales Area and Its Competitors
Table 112. QILU Oncology/Cancer Drugs Product Offered
Table 113. QILU Oncology/Cancer Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 114. QILU Main Business
Table 115. QILU Latest Developments
Table 116. Sanofi Basic Information, Oncology/Cancer Drugs Manufacturing Base, Sales Area and Its Competitors
Table 117. Sanofi Oncology/Cancer Drugs Product Offered
Table 118. Sanofi Oncology/Cancer Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 119. Sanofi Main Business
Table 120. Sanofi Latest Developments
Table 121. HANSOH Basic Information, Oncology/Cancer Drugs Manufacturing Base, Sales Area and Its Competitors
Table 122. HANSOH Oncology/Cancer Drugs Product Offered
Table 123. HANSOH Oncology/Cancer Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 124. HANSOH Main Business
Table 125. HANSOH Latest Developments
Table 126. LUYE Basic Information, Oncology/Cancer Drugs Manufacturing Base, Sales Area and Its Competitors
Table 127. LUYE Oncology/Cancer Drugs Product Offered
Table 128. LUYE Oncology/Cancer Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 129. LUYE Main Business
Table 130. LUYE Latest Developments
Table 131. Novartis Basic Information, Oncology/Cancer Drugs Manufacturing Base, Sales Area and Its Competitors
Table 132. Novartis Oncology/Cancer Drugs Product Offered
Table 133. Novartis Oncology/Cancer Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 134. Novartis Main Business
Table 135. Novartis Latest Developments
Table 136. GuiZhou YiBai Basic Information, Oncology/Cancer Drugs Manufacturing Base, Sales Area and Its Competitors
Table 137. GuiZhou YiBai Oncology/Cancer Drugs Product Offered
Table 138. GuiZhou YiBai Oncology/Cancer Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 139. GuiZhou YiBai Main Business
Table 140. GuiZhou YiBai Latest Developments
Table 141. Lunan Basic Information, Oncology/Cancer Drugs Manufacturing Base, Sales Area and Its Competitors
Table 142. Lunan Oncology/Cancer Drugs Product Offered
Table 143. Lunan Oncology/Cancer Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 144. Lunan Main Business
Table 145. Lunan Latest Developments
Table 146. Eli Lilly and Company Basic Information, Oncology/Cancer Drugs Manufacturing Base, Sales Area and Its Competitors
Table 147. Eli Lilly and Company Oncology/Cancer Drugs Product Offered
Table 148. Eli Lilly and Company Oncology/Cancer Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 149. Eli Lilly and Company Main Business
Table 150. Eli Lilly and Company Latest Developments
LIST OF FIGURES
Figure 1. Picture of Oncology/Cancer Drugs
Figure 2. Oncology/Cancer Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Oncology/Cancer Drugs Sales Growth Rate 2017-2028 (K MT)
Figure 7. Global Oncology/Cancer Drugs Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Oncology/Cancer Drugs Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Antimetabolite
Figure 10. Product Picture of Alkaloid drugs
Figure 11. Product Picture of Hormone
Figure 12. Product Picture of Targeted drug
Figure 13. Product Picture of Platinum-based drugs
Figure 14. Product Picture of Other
Figure 15. Global Oncology/Cancer Drugs Sales Market Share by Type in 2021
Figure 16. Global Oncology/Cancer Drugs Revenue Market Share by Type (2017-2022)
Figure 17. Oncology/Cancer Drugs Consumed in Blood Cancer
Figure 18. Global Oncology/Cancer Drugs Market: Blood Cancer (2017-2022) & (K MT)
Figure 19. Oncology/Cancer Drugs Consumed in Breast Cancer
Figure 20. Global Oncology/Cancer Drugs Market: Breast Cancer (2017-2022) & (K MT)
Figure 21. Oncology/Cancer Drugs Consumed in Gastrointestinal Cancer
Figure 22. Global Oncology/Cancer Drugs Market: Gastrointestinal Cancer (2017-2022) & (K MT)
Figure 23. Oncology/Cancer Drugs Consumed in Prostate Cancer
Figure 24. Global Oncology/Cancer Drugs Market: Prostate Cancer (2017-2022) & (K MT)
Figure 25. Oncology/Cancer Drugs Consumed in Respiratory/Lung Cancer
Figure 26. Global Oncology/Cancer Drugs Market: Respiratory/Lung Cancer (2017-2022) & (K MT)
Figure 27. Oncology/Cancer Drugs Consumed in Other
Figure 28. Global Oncology/Cancer Drugs Market: Other (2017-2022) & (K MT)
Figure 29. Global Oncology/Cancer Drugs Sales Market Share by Application (2017-2022)
Figure 30. Global Oncology/Cancer Drugs Revenue Market Share by Application in 2021
Figure 31. Oncology/Cancer Drugs Revenue Market by Company in 2021 ($ Million)
Figure 32. Global Oncology/Cancer Drugs Revenue Market Share by Company in 2021
Figure 33. Global Oncology/Cancer Drugs Sales Market Share by Geographic Region (2017-2022)
Figure 34. Global Oncology/Cancer Drugs Revenue Market Share by Geographic Region in 2021
Figure 35. Global Oncology/Cancer Drugs Sales Market Share by Region (2017-2022)
Figure 36. Global Oncology/Cancer Drugs Revenue Market Share by Country/Region in 2021
Figure 37. Americas Oncology/Cancer Drugs Sales 2017-2022 (K MT)
Figure 38. Americas Oncology/Cancer Drugs Revenue 2017-2022 ($ Millions)
Figure 39. APAC Oncology/Cancer Drugs Sales 2017-2022 (K MT)
Figure 40. APAC Oncology/Cancer Drugs Revenue 2017-2022 ($ Millions)
Figure 41. Europe Oncology/Cancer Drugs Sales 2017-2022 (K MT)
Figure 42. Europe Oncology/Cancer Drugs Revenue 2017-2022 ($ Millions)
Figure 43. Middle East & Africa Oncology/Cancer Drugs Sales 2017-2022 (K MT)
Figure 44. Middle East & Africa Oncology/Cancer Drugs Revenue 2017-2022 ($ Millions)
Figure 45. Americas Oncology/Cancer Drugs Sales Market Share by Country in 2021
Figure 46. Americas Oncology/Cancer Drugs Revenue Market Share by Country in 2021
Figure 47. United States Oncology/Cancer Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 48. Canada Oncology/Cancer Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 49. Mexico Oncology/Cancer Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 50. Brazil Oncology/Cancer Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 51. APAC Oncology/Cancer Drugs Sales Market Share by Region in 2021
Figure 52. APAC Oncology/Cancer Drugs Revenue Market Share by Regions in 2021
Figure 53. China Oncology/Cancer Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 54. Japan Oncology/Cancer Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 55. South Korea Oncology/Cancer Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 56. Southeast Asia Oncology/Cancer Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 57. India Oncology/Cancer Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 58. Australia Oncology/Cancer Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 59. Europe Oncology/Cancer Drugs Sales Market Share by Country in 2021
Figure 60. Europe Oncology/Cancer Drugs Revenue Market Share by Country in 2021
Figure 61. Germany Oncology/Cancer Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 62. France Oncology/Cancer Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 63. UK Oncology/Cancer Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 64. Italy Oncology/Cancer Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 65. Russia Oncology/Cancer Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 66. Middle East & Africa Oncology/Cancer Drugs Sales Market Share by Country in 2021
Figure 67. Middle East & Africa Oncology/Cancer Drugs Revenue Market Share by Country in 2021
Figure 68. Egypt Oncology/Cancer Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 69. South Africa Oncology/Cancer Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 70. Israel Oncology/Cancer Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 71. Turkey Oncology/Cancer Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 72. GCC Country Oncology/Cancer Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 73. Manufacturing Cost Structure Analysis of Oncology/Cancer Drugs in 2021
Figure 74. Manufacturing Process Analysis of Oncology/Cancer Drugs
Figure 75. Industry Chain Structure of Oncology/Cancer Drugs
Figure 76. Channels of Distribution
Figure 77. Distributors Profiles
Figure 1. Picture of Oncology/Cancer Drugs
Figure 2. Oncology/Cancer Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Oncology/Cancer Drugs Sales Growth Rate 2017-2028 (K MT)
Figure 7. Global Oncology/Cancer Drugs Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Oncology/Cancer Drugs Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Antimetabolite
Figure 10. Product Picture of Alkaloid drugs
Figure 11. Product Picture of Hormone
Figure 12. Product Picture of Targeted drug
Figure 13. Product Picture of Platinum-based drugs
Figure 14. Product Picture of Other
Figure 15. Global Oncology/Cancer Drugs Sales Market Share by Type in 2021
Figure 16. Global Oncology/Cancer Drugs Revenue Market Share by Type (2017-2022)
Figure 17. Oncology/Cancer Drugs Consumed in Blood Cancer
Figure 18. Global Oncology/Cancer Drugs Market: Blood Cancer (2017-2022) & (K MT)
Figure 19. Oncology/Cancer Drugs Consumed in Breast Cancer
Figure 20. Global Oncology/Cancer Drugs Market: Breast Cancer (2017-2022) & (K MT)
Figure 21. Oncology/Cancer Drugs Consumed in Gastrointestinal Cancer
Figure 22. Global Oncology/Cancer Drugs Market: Gastrointestinal Cancer (2017-2022) & (K MT)
Figure 23. Oncology/Cancer Drugs Consumed in Prostate Cancer
Figure 24. Global Oncology/Cancer Drugs Market: Prostate Cancer (2017-2022) & (K MT)
Figure 25. Oncology/Cancer Drugs Consumed in Respiratory/Lung Cancer
Figure 26. Global Oncology/Cancer Drugs Market: Respiratory/Lung Cancer (2017-2022) & (K MT)
Figure 27. Oncology/Cancer Drugs Consumed in Other
Figure 28. Global Oncology/Cancer Drugs Market: Other (2017-2022) & (K MT)
Figure 29. Global Oncology/Cancer Drugs Sales Market Share by Application (2017-2022)
Figure 30. Global Oncology/Cancer Drugs Revenue Market Share by Application in 2021
Figure 31. Oncology/Cancer Drugs Revenue Market by Company in 2021 ($ Million)
Figure 32. Global Oncology/Cancer Drugs Revenue Market Share by Company in 2021
Figure 33. Global Oncology/Cancer Drugs Sales Market Share by Geographic Region (2017-2022)
Figure 34. Global Oncology/Cancer Drugs Revenue Market Share by Geographic Region in 2021
Figure 35. Global Oncology/Cancer Drugs Sales Market Share by Region (2017-2022)
Figure 36. Global Oncology/Cancer Drugs Revenue Market Share by Country/Region in 2021
Figure 37. Americas Oncology/Cancer Drugs Sales 2017-2022 (K MT)
Figure 38. Americas Oncology/Cancer Drugs Revenue 2017-2022 ($ Millions)
Figure 39. APAC Oncology/Cancer Drugs Sales 2017-2022 (K MT)
Figure 40. APAC Oncology/Cancer Drugs Revenue 2017-2022 ($ Millions)
Figure 41. Europe Oncology/Cancer Drugs Sales 2017-2022 (K MT)
Figure 42. Europe Oncology/Cancer Drugs Revenue 2017-2022 ($ Millions)
Figure 43. Middle East & Africa Oncology/Cancer Drugs Sales 2017-2022 (K MT)
Figure 44. Middle East & Africa Oncology/Cancer Drugs Revenue 2017-2022 ($ Millions)
Figure 45. Americas Oncology/Cancer Drugs Sales Market Share by Country in 2021
Figure 46. Americas Oncology/Cancer Drugs Revenue Market Share by Country in 2021
Figure 47. United States Oncology/Cancer Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 48. Canada Oncology/Cancer Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 49. Mexico Oncology/Cancer Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 50. Brazil Oncology/Cancer Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 51. APAC Oncology/Cancer Drugs Sales Market Share by Region in 2021
Figure 52. APAC Oncology/Cancer Drugs Revenue Market Share by Regions in 2021
Figure 53. China Oncology/Cancer Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 54. Japan Oncology/Cancer Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 55. South Korea Oncology/Cancer Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 56. Southeast Asia Oncology/Cancer Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 57. India Oncology/Cancer Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 58. Australia Oncology/Cancer Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 59. Europe Oncology/Cancer Drugs Sales Market Share by Country in 2021
Figure 60. Europe Oncology/Cancer Drugs Revenue Market Share by Country in 2021
Figure 61. Germany Oncology/Cancer Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 62. France Oncology/Cancer Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 63. UK Oncology/Cancer Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 64. Italy Oncology/Cancer Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 65. Russia Oncology/Cancer Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 66. Middle East & Africa Oncology/Cancer Drugs Sales Market Share by Country in 2021
Figure 67. Middle East & Africa Oncology/Cancer Drugs Revenue Market Share by Country in 2021
Figure 68. Egypt Oncology/Cancer Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 69. South Africa Oncology/Cancer Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 70. Israel Oncology/Cancer Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 71. Turkey Oncology/Cancer Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 72. GCC Country Oncology/Cancer Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 73. Manufacturing Cost Structure Analysis of Oncology/Cancer Drugs in 2021
Figure 74. Manufacturing Process Analysis of Oncology/Cancer Drugs
Figure 75. Industry Chain Structure of Oncology/Cancer Drugs
Figure 76. Channels of Distribution
Figure 77. Distributors Profiles
